New Research on Osteosarcomas from Second Affiliated Hospital of Zhengzhou University Summarized ([223Ra] RaCl2 nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era)

Press/Media: Research

PeriodDec 12 2022

Media coverage

1

Media coverage

  • TitleNew Research on Osteosarcomas from Second Affiliated Hospital of Zhengzhou University Summarized ([223Ra] RaCl2 nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era)
    Media name/outletClinical Trials Daily
    Country/TerritoryUnited States
    Date12/12/22
    PersonsYang Yang